Strategic Mgg Sa Sif Sicaf Strategic Mgg Net Worth & Insider Trades

Strategic Mgg Sa Sif Sicaf Strategic Mgg Royalty Pharma Plc

As of December 5, 2022

What is Strategic Mgg Sa Sif Sicaf Strategic Mgg's Net Worth?

The current estimated net worth of Royalty Pharma Plc's Strategic Mgg Sa Sif Sicaf Strategic Mgg is estimated to be about $70.26M . Strategic Mgg Sa Sif Sicaf Strategic Mgg owns about 11,356,894 units of Royalty Pharma Plc common stock. In the last 3 months at Royalty Pharma Plc, Strategic Mgg Sa Sif Sicaf Strategic Mgg has sold an estimated value of $68.22M worth.

What is Strategic Mgg Sa Sif Sicaf Strategic Mgg's Past Insider Trading?

Strategic Mgg Sa Sif Sicaf Strategic Mgg's largest sale order was 523,842 units , worth over $21.52M on September 22, 2022. In total, Strategic Mgg Sa Sif Sicaf Strategic Mgg has made about 4 transactions over 3 months of their time at Royalty Pharma Plc. Strategic Mgg Sa Sif Sicaf Strategic Mgg usually trades in September, with the busiest year in 2022. The most recent transaction was a sale order of 362,766 units , worth over $15.97M on December 5, 2022.

Germano Mario Giuliani, Strategic MGG SA SIF SICAF Strategic MGG, SA SIF SICAF Strategic MGG, Skyeline Management Ltd, Avara Management Ltd

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Strategic Mgg Sa Sif Sicaf Strategic Mgg's' Mailing Address?

  • Mailing address is 18 Avenue de la Porte Neuve Luxembourg N4 L-2227 Luxembourg

Royalty Pharma Plc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Pablo Legorreta Pablo Legorreta 2020 $55,674,558 $55,674,558 $55,674,558 $55,674,558
Pablo Legorreta Pablo Legorreta 2019 $28,545,792 $28,545,792 $28,545,792 $28,545,792
Terrance Coyne Terrance Coyne 2020 $3,395,000 $3,395,000 - $3,395,000
Terrance Coyne Terrance Coyne 2019 $1,925,625 $1,925,625 - $1,925,625
Christopher Hite 2020 $3,644,711 $3,644,711 $367,788 $3,644,711
Christopher Hite 2019 - - - -
George Lloyd George Lloyd 2020 $3,395,000 $3,395,000 - $3,395,000
George Lloyd George Lloyd 2019 $2,182,500 $2,182,500 - $2,182,500
James Reddoch, Ph.D. James Reddoch, Ph.D. 2020 $3,395,000 $3,395,000 - $3,395,000
James Reddoch, Ph.D. James Reddoch, Ph.D. 2019 $2,082,500 $2,082,500 - $2,082,500
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1802768/000114036121014879/nc10022939x1_def14a.htm

What are Royalty Pharma Plc's Past Insider Trades?

Royalty Pharma Plc's most recent insider trade came on December 7, 2022 by Germano Mario Giuliani, Skyeline Management Ltd and Avara Management Ltd who sold 84,302 units worth $3.64M . In the last 6 years, insiders at Royalty Pharma Plc have sold an estimated value of $727.81M and bought an estimated value of $146.45M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are George W Lloyd, EVP,  James F Reddoch, EVP & Chief Scientific Officer,  and Rory B Riggs, Director .

REPROS THERAPEUTICS INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1